SnapShot™ Platform Development

About Surf Bio

Surf Bio is a private, preclinical-stage biotech leveraging its proprietary Surf SnapShot™ platform to revolutionize the subcutaneous delivery of biologics. Its core innovation is a polymer-based excipient that stabilizes proteins at unprecedented concentrations (>600 mg/mL), enabling high-dose, at-home administration of drugs that currently require clinic-based IV infusions. With a seasoned leadership team from Bigfoot Biomedical and Stanford, and backed by partnerships with major pharma companies, Surf Bio aims to significantly improve patient access and convenience across multiple chronic disease areas.

Therapeutic Areas